Skip to content
OpenCapital
Get started

LivaNova LIVN Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

ICU Medical logo
ICU MedicalICUI
——

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's amortization expense related to capitalized debt issuance costs?
LivaNova (LIVN) reported amortization expense related to capitalized debt issuance costs of $4.77M in Q1 2026.
How has LivaNova's amortization expense related to capitalized debt issuance costs changed year-over-year?
LivaNova's amortization expense related to capitalized debt issuance costs decreased by 16.0% year-over-year, from $5.68M to $4.77M.
What is the long-term trend for LivaNova's amortization expense related to capitalized debt issuance costs?
Over 4 years (2021 to 2025), LivaNova's amortization expense related to capitalized debt issuance costs has grown at a 8.5% compound annual growth rate (CAGR), from $16.66M to $23.08M.